Methotrexate-vindesine Association in Head and Neck Cancer: Modification of Methotrexate's Hydroxylation in Presence of Vindesine

Overview

Journal Cancer Chemother Pharmacol

Specialty Oncology

Date 1986 Jan 1

PMID 3719898

Citations 1

Authors

P Bore

N Lena

A M Imbert

R Favre

J P Cano

G Meyer

Y Carcassonne

Affiliations

Soon will be listed here.

Abstract

High-dose methotrexate (HD-MTX) infusions associated with vindesine (VDS) have been used in the treatment of head and neck cancer. In a previous study, VDS was shown to increase the apparent plasma clearance of MTX. We have studied the MTX hydroxylation process in the presence of VDS. Different routes of administration have been tested (IV pushes and 24-h or 36-h infusions). A radioimmunoassay has been developed to measure 7-OH-MTX. The defined protocols enabled us to show that VDS influences not only the pharmacokinetic behavior of methotrexate but also its hydroxylation, which is decreased in presence of VDS.

Citing Articles

Pharmacokinetic drug interactions with anticancer drugs.

Loadman P, Bibby M Clin Pharmacokinet. 1994; 26(6):486-500.

PMID: 8070221 DOI: 10.2165/00003088-199426060-00006.

References

Warren R, Nichols A, Bender R . The effect of vincristine on methotrexate uptake and inhibition of DNA synthesis by human lymphoblastoid cells. Cancer Res. 1977; 37(9):2993-7. View

Plasse T, Ohnuma T, Brooks S, Saponaro E, HOLLAND J, Biller H . Bleomycin infusion followed by cyclophosphamide, methotrexate, and 5-fluorouracil in advanced squamous carcinoma of the head and neck. Cancer. 1984; 53(4):841-3. DOI: 10.1002/1097-0142(19840215)53:4<841::aid-cncr2820530404>3.0.co;2-z. View

Bertino J, Fischer G . TECHNIQUES FOR STUDY OF RESISTANCE TO FOLIC ACID ANTAGONISTS. Methods Med Res. 1964; 10:297-307. View

Zager R, Frisby S, OLIVERIO V . The effects of antibiotics and cancer chemotherapeutic agents on the cellular transport and antitumor activity of methotrexate in L1210 murine leukemia. Cancer Res. 1973; 33(7):1670-6. View

Hortobagyi G, Yap H, Blumenschein G, Buzdar A, BARNES B, Legha S . Phase II evaluation of vinblastine, methotrexate, and calcium leukovorin rescue in patients with refractory metastatic breast cancer. Cancer. 1983; 51(5):769-72. DOI: 10.1002/1097-0142(19830301)51:5<769::aid-cncr2820510503>3.0.co;2-s. View

Benz C, Tillis T, Tattelman E, Cadman E . Optimal schedule of methotrexate and 5-fluorouracil in human breast cancer. Cancer Res. 1982; 42(5):2081-6. View

Gewirtz A, Cadman E . Preliminary report on the efficacy of sequential methotrexate and 5-fluorouracil in advanced breast cancer. Cancer. 1981; 47(11):2552-5. DOI: 10.1002/1097-0142(19810601)47:11<2552::aid-cncr2820471106>3.0.co;2-y. View

Ervin T, Kirkwood J, Weichselbaum R, Miller D, Pitman S, Frei 3rd E . Improved survival for patients with advanced carcinoma of the head and neck treated with methotrexate-leucovorin prior to definitive radiotherapy or surgery. Laryngoscope. 1981; 91(7):1181-90. DOI: 10.1288/00005537-198107000-00018. View

Imbert A, Pignon T, Lena N . Enzymatic assay for methotrexate with a centrifugal analyzer (Cobas-Bio). Clin Chem. 1983; 29(6):1317-8. View

10.

Ervin T, Weichselbaum R, Miller D, Meshad M, Posner M, Fabian R . Treatment of advanced squamous cell carcinoma of the head and neck with cisplatin, bleomycin, and methotrexate (PBM). Cancer Treat Rep. 1981; 65(9-10):787-91. View

11.

Johns D, IANNOTTI A, Sartorelli A, BOOTH B, Bertino J . The identity of rabbit-liver methotrexate oxidase. Biochim Biophys Acta. 1965; 105(2):380-2. DOI: 10.1016/s0926-6593(65)80164-3. View

12.

Lena N, Imbert A, Pignon T, Favre R, Meyer G, Cano J . Methotrexate-vindesine association in the treatment of head and neck cancer influence of vindesine on methotrexate's pharmacokinetic behavior. Cancer Chemother Pharmacol. 1984; 12(2):120-4. DOI: 10.1007/BF00254603. View

13.

Schornagel J, McVie J . The clinical pharmacology of methotrexate. Cancer Treat Rev. 1983; 10(1):53-75. DOI: 10.1016/s0305-7372(83)80032-2. View

14.

Fyfe M, Goldman I . Characteristics of the vincristine-induced augmentation of methotrexate uptake in Ehrlich ascites tumor cells. J Biol Chem. 1973; 248(14):5067-73. View

15.

Chello P, Sirotnak F, Dorick D . Different effects of vincristine on methotrexate uptake by L1210 cells and mouse intestinal epithelia in vitro and in vivo. Cancer Res. 1979; 39(6 Pt 1):2106-12. View

16.

Jacobs S, Stoller R, Chabner B, Johns D . Dose-dependent metabolism of methotrexate in man and rhesus monkeys. Cancer Treat Rep. 1977; 61(4):651-6. View

17.

Jacobs C . Use of methotrexate and 5-FU for recurrent head and neck cancer. Cancer Treat Rep. 1982; 66(11):1925-8. View

18.

Strum W, LIEM H, Muller-Eberhard U . Effect of chemotherapeutic agents on the uptake and excretion of amethopterin by the isolated perfused rat liver. Cancer Res. 1978; 38(12):4734-6. View

19.

CAPPELAERE P, Chauvergne J, Klein T, GARY-BOBO J, Guerrin J, Meeus L . [Randomized trial of vincristin-methotrexate-bleomycin and cis-platin or detorubicin for advanced head and neck cancer (author's transl)]. Bull Cancer. 1981; 68(5):422-7. View

20.

Bore P, Rahmani R, Cano J, Just S, Barbet J . Radioimmunoassays of 7-hydroxymethotrexate and methotrexate. Clin Chim Acta. 1984; 141(2-3):135-49. DOI: 10.1016/0009-8981(84)90006-8. View